Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...
A novel CRISPR defense mechanism, unlike known nucleases, specifically destroys transfer ribonucleic acids (tRNA) that are ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...
Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...
Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
USU chemists’ CRISPR discovery could lead to single diagnostic test for viruses like COVID, flu, RSV
Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...
An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...
Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback